Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range

8 April 2008

journal article
Published by Informa Healthcare in Current Medical Research and Opinion

Vol. 24 (5) , 1455-1458
https://doi.org/10.1185/030079908x301875

Abstract

Atrial fibrillation (AF) is a growing epidemic in the developed world that has attracted much attention due to the associated risk of stroke and thromboembolism. This article discusses the application of oral anticoagulation (OAC) therapy with vitamin K antagonists (VKA) in order to reduce these risks. The article provides an overview of OAC management and highlights the need for greater efforts to increase time within therapeutic range.

Keywords

INR
ORAL ANTICOAGULANT
STROKE
VITAMIN K ANTAGONISTS

This publication has 17 references indexed in Scilit:

Anticoagulation for elderly patients with atrial fibrillation: not to be neglected
EP Europace, 2007
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
The Lancet, 2007
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
EP Europace, 2006
Translating the Results of Randomized Trials into Clinical Practice
Stroke, 2006
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment
Age and Ageing, 2005
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
Heart, 2004
Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation Therapy
Stroke, 2002
Universities and tobacco money
BMJ, 2001
Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Annals of Internal Medicine, 1999
Physician variation in the management of patients with atrial fibrillation.
Heart, 1996